Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with newly diagnosed or recurrent/refractory (R/R) glioblastoma (GBM): Phase 1b/2 study update Meeting Abstract

   

Authors:	Piotrowski, A.; Puduvalli, V.; Wen, P.; Campian, J.; Colman, H.; Pearlman, M.; Butowski, N.; Battiste, J.; Glass, J.; Cloughesy, T.; Schiff, D.; van den Bent, M.; Walbert, T.; Ahluwalia, M.; Badruddoja, M.; Kalra, A.; Aregawi, D.; Weller, M.; Ramakrishnan, V.; Zhang, K.; Wood, K.; Mellinghoff, I.; Shih, K.
Abstract Title:	Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with newly diagnosed or recurrent/refractory (R/R) glioblastoma (GBM): Phase 1b/2 study update
Meeting Title:	24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title:	Neuro-Oncology
Volume:	21
Issue:	Suppl. 6
Meeting Dates:	2019 Nov 22-24
Meeting Location:	Phoenix, AZ
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2019-11-01
Start Page:	vi21
End Page:	vi22
Language:	English
ACCESSION:	WOS:000509478700082
PROVIDER:	wos
PMCID:	PMC6847934
DOI:	10.1093/neuonc/noaa215.205
Notes:	Meeting Abstract: ACTR-39 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/162549